These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29750088)

  • 1. Oxidative Stress in Patients Undergoing Peritoneal Dialysis: A Current Review of the Literature.
    Liakopoulos V; Roumeliotis S; Gorny X; Eleftheriadis T; Mertens PR
    Oxid Med Cell Longev; 2017; 2017():3494867. PubMed ID: 29750088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is oxidative stress an issue in peritoneal dialysis?
    Roumeliotis S; Eleftheriadis T; Liakopoulos V
    Semin Dial; 2019 Sep; 32(5):463-466. PubMed ID: 31044475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for Biocompatible Peritoneal Dialysis Solutions.
    Nataatmadja M; Cho Y; Johnson DW
    Contrib Nephrol; 2017; 189():91-101. PubMed ID: 27951555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal dialysis and inflammation.
    Velloso MS; Otoni A; de Paula Sabino A; de Castro WV; Pinto SW; Marinho MA; Rios DR
    Clin Chim Acta; 2014 Mar; 430():109-14. PubMed ID: 24333488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress.
    Roumeliotis S; Dounousi E; Salmas M; Eleftheriadis T; Liakopoulos V
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32423139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of Protein Oxidative Stress, Antioxidant Vitamins and Inflammation in Patients Undergoing either Hemodialysis or Peritoneal Dialysis.
    Marques de Mattos A; Afonso Jordão A; Abrão Cardeal da Costa J; Garcia Chiarello P
    Int J Vitam Nutr Res; 2014; 84(5-6):261-8. PubMed ID: 26255547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, inflammation, and peritoneal dialysis: A molecular biology approach.
    Innico G; Gobbi L; Bertoldi G; Rigato M; Basso A; Bonfante L; Calò LA
    Artif Organs; 2021 Oct; 45(10):1202-1207. PubMed ID: 34037984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions.
    Williams JD; Craig KJ; Topley N; Williams GT
    Kidney Int Suppl; 2003 May; (84):S158-61. PubMed ID: 12694335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis.
    de Lima SM; Otoni A; Sabino Ade P; Dusse LM; Gomes KB; Pinto SW; Marinho MA; Rios DR
    Clin Chim Acta; 2013 Jun; 421():46-50. PubMed ID: 23466603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Residual Renal Function in Carotid Modeling as a Marker of Early Atherosclerosis in Dialysis Patients.
    Rroji M; Spahia N; Seferi S; Barbullushi M; Spasovski G
    Ther Apher Dial; 2017 Oct; 21(5):451-458. PubMed ID: 28714271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?
    Perl J; Nessim SJ; Bargman JM
    Kidney Int; 2011 Apr; 79(8):814-24. PubMed ID: 21248712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Biocompatible" Neutral pH Low-GDP Peritoneal Dialysis Solutions: Much Ado About Nothing?
    Misra PS; Nessim SJ; Perl J
    Semin Dial; 2017 Mar; 30(2):164-173. PubMed ID: 28251697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal Membrane Preservation.
    Bajo MA; Del Peso G; Teitelbaum I
    Semin Nephrol; 2017 Jan; 37(1):77-92. PubMed ID: 28153197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions.
    Yao Q; Pawlaczyk K; Ayala ER; Styszynski A; Breborowicz A; Heimburger O; Qian JQ; Stenvinkel P; Lindholm B; Axelsson J
    Nephron Exp Nephrol; 2008; 109(2):e71-8. PubMed ID: 18600031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatible peritoneal dialysis solutions: do we have one?
    Chaudhary K; Khanna R
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):723-32. PubMed ID: 20093342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dialysis modality and cardiac disease in chronic kidney insufficiency].
    Grzegorzewska AE
    Pol Merkur Lekarski; 2006 Apr; 20(118):453-6. PubMed ID: 16886575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulating Peritoneal Sclerosis.
    Alston H; Fan S; Nakayama M
    Semin Nephrol; 2017 Jan; 37(1):93-102. PubMed ID: 28153198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
    Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.